The airway epithelium protects us from environmental insults, which we encounter with
every breath. Not only does it passively filter large particles, it also senses potential danger …

Idiopathic pulmonary fibrosis (IPF) is a fatal disease with incompletely understood aetiology
and limited treatment options. Traditionally, IPF was believed to be mainly caused by …

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and
limited treatment options. Efforts to identify effective treatments are thwarted by limited …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited
therapeutic options, and there is a huge unmet need for new therapies. A growing body of …

Asthma is a chronic inflammatory lung disease with intermittent flares predominately
mediated through memory T cells. Yet, the identity of long-term memory cells that mediate …

Rationale: To improve disease outcomes in idiopathic pulmonary fibrosis (IPF), it is essential
to understand its early pathophysiology so that it can be targeted therapeutically. Objectives …

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with unknown etiological factors
that can progress to other dangerous diseases like lung cancer. Environmental and genetic …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has led to the initiation of
unprecedented research efforts to understand the pathogenesis mediated by Severe Acute …

Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …

Fibrosis is a pathological condition characterized by the excessive deposition of
extracellular matrix components in tissues and organs, leading to progressive architectural …